PUTNAM INVESTMENTS LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q4 2021$2,689,000
-75.8%
56,388
-66.3%
0.00%
-76.5%
Q3 2021$11,103,000
-14.9%
167,145
-0.0%
0.02%
-15.0%
Q2 2021$13,042,000
+147.2%
167,159
+199.8%
0.02%
+122.2%
Q1 2021$5,275,000
-20.9%
55,759
+1.9%
0.01%
-25.0%
Q4 2020$6,666,00054,7050.01%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders